Irvalec Inserts into the Plasma Membrane Causing Rapid Loss of Integrity and Necrotic Cell Death in Tumor Cells

Irvalec is a marine-derived antitumor agent currently undergoing phase II clinical trials. In vitro, Irvalec induces a rapid loss of membrane integrity in tumor cells, accompanied of a significant Ca(2+) influx, perturbations of membrane conductivity, severe swelling and the formation of giant membr...

Descripción completa

Detalles Bibliográficos
Autores principales: Molina-Guijarro, José M., Macías, Álvaro, García, Carolina, Muñoz, Eva, García-Fernández, Luis F., David, Miren, Núñez, Lucía, Martínez-Leal, Juan F., Moneo, Victoria, Cuevas, Carmen, Lillo, M. Pilar, Villalobos Jorge, Carlos, Valenzuela, Carmen, Galmarini, Carlos M.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083409/
https://www.ncbi.nlm.nih.gov/pubmed/21556352
http://dx.doi.org/10.1371/journal.pone.0019042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083409/
https://www.ncbi.nlm.nih.gov/pubmed/21556352
http://dx.doi.org/10.1371/journal.pone.0019042

Ejemplares similares